FDA Adverse Event Injury Summary report: N

CARPENTIER-EDWARDS® PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESES

MDR report key: 2891646 · Received December 31, 2012

Report

Report Number
2015691-2012-18980
Event Type
Injury
Date Received
December 31, 2012
Date of Event
October 31, 2012
Report Date
December 3, 2012
Manufacturer
EDWARDS LIFESCIENCES
Product Code
DYE
PMA / PMN Number
P860057/S068
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

EXPLANTS AT IMPLANT ARE TYPICALLY A RESULT OF INAPPROPRIATE SIZING, DISTORTION OF THE VALVE DURING IMPLANTATION AND/OR THE PATIENT'S ANATOMY, AND NOT A MALFUNCTION OF THE DEVICE. AFTER A VALVE IS IMPLANTED, THE PATIENT IS WEANED FROM CARDIOPULMONARY BYPASS (CPB). FIRST, THE HEART IS WARMED AND ALLOWED TO SPONTANEOUSLY BEAT. THEN, THE HEART IS ALLOWED TO FILL GRADUALLY AS CPB IS DECREASED. DURING THIS TIME A TEE IS ROUTINELY PERFORMED TO CHECK VALVE FUNCTION. IF THE VALVE IS FUNCTIONING NORMALLY, BYPASS WILL BE DISCONTINUED AND THE AORTIC/VENOUS CANNULAE ARE REMOVED. THERE MAY BE CASES IN WHICH REGURGITATION IS DETECTED BY TEE PRIOR TO THE COMPLETE DISCONTINUATION OF CPB AND REMOVAL OF CANNULAE. IF THERE IS EVIDENCE OF INTERVENTION REQUIRED AFTER COMPLETE DISCONTINUATION OF CPB AND REMOVAL OF CANNULAE (FOR EXAMPLE LEAFLET NOT COAPTING), THIS MAY REQUIRE SIGNIFICANTLY EXTENDED OPERATIVE AND CARDIOPULMONARY BYPASS TIME, WHICH INCREASES THE RISK OF THE PROCEDURE. THROUGH FOLLOW UP WITH THE SURGEON, IT WAS LEARNED THAT THE DEVICE WAS REMOVED PRIOR TO THE PATIENT COMING OFF CPB IN THIS CASE. THEREFORE, THERE WAS NO INCREASE IN RISK DUE TO THE EXPLANT. IT WAS ALSO CONFIRMED THAT THERE WAS NO MALFUNCTION OR DEFICIENCY OF THE VALVE. NO FURTHER ACTIONS ARE BEING TAKEN.

Additional Manufacturer Narrative · 1

METHOD: DEVICE NOT RETURNED. IT IS UNKNOWN IF THE DEVICE IS AVAILABLE FOR RETURN AND EVALUATION. REASON FOR EXPLANT IS UNKNOWN. THE DEVICE HISTORY RECORD (DHR) REVIEW IS IN PROGRESS.

Description of Event or Problem · 1

EDWARDS LIFESCIENCES MAINTAINS AN IMPLANT PATIENT REGISTRY. THIS REGISTRY IS A PATIENT TRACKING MECHANISM FOR SERIALIZED EDWARDS IMPLANTABLE DEVICES (BIOPROSTHETIC HEART VALVES AND ANNULOPLASTY RINGS), RATHER THAN A TRUE POST-MARKET SURVEILLANCE REGISTRY. THROUGH THE REGISTRY, EDWARDS IS NOTIFIED WHEN THESE DEVICES ARE IMPLANTED. IN ADDITION, PATIENT AND/OR DEVICE STATUS MAY BE REPORTED TO THE REGISTRY VIA THE IMPLANTATION DATA CARDS. THE INFORMATION IS RECEIVED FROM VARIOUS SOURCES (E.G. SURGEON, HOSPITAL, AND PATIENT FAMILY MEMBERS) AND IS NOT RECEIVED IN THE FORM OF A CONVENTIONAL "CUSTOMER COMPLAINT". THE INFORMATION REPORTED MAY OR MAY NOT BE RELATED TO THE EDWARDS DEVICE. IN THIS CASE, A 33 MM MITRAL VALVE WAS EXPLANTED AT IMPLANT AND REPLACED WITH A 31MM MITRAL VALVE - SAME MODEL DEVICE - DUE TO UNKNOWN REASONS. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CARPENTIER-EDWARDS® PERIMOUNT MAGNA MITRAL EASE PERICARDIAL BIOPROSTHESES REPLACEMENT HEART VALVE DYE EDWARDS LIFESCIENCES 7300TFX33

Patients

Seq Age Sex Outcome Treatment
1 48 YR Hospitalization| R